BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10464147)

  • 1. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.
    Meerman L; Koopen NR; Bloks V; Van Goor H; Havinga R; Wolthers BG; Kramer W; Stengelin S; Müller M; Kuipers F; Jansen PL
    Gastroenterology; 1999 Sep; 117(3):696-705. PubMed ID: 10464147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice.
    Bloks VW; Plösch T; van Goor H; Roelofsen H; Baller J; Havinga R; Verkade HJ; van Tol A; Jansen PL; Kuipers F
    J Lipid Res; 2001 Jan; 42(1):41-50. PubMed ID: 11160364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria.
    Libbrecht L; Meerman L; Kuipers F; Roskams T; Desmet V; Jansen P
    J Pathol; 2003 Feb; 199(2):191-200. PubMed ID: 12533832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria.
    Plösch T; Bloks VW; Baller JF; Havinga R; Verkade HJ; Jansen PL; Kuipers F
    Hepatology; 2002 Feb; 35(2):299-306. PubMed ID: 11826402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
    Lyoumi S; Abitbol M; Rainteau D; Karim Z; Bernex F; Oustric V; Millot S; Lettéron P; Heming N; Guillmot L; Montagutelli X; Berdeaux G; Gouya L; Poupon R; Deybach JC; Beaumont C; Puy H
    Gastroenterology; 2011 Oct; 141(4):1509-19, 1519.e1-3. PubMed ID: 21762662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of fecal fat excretion and the disposal of protoporphyrin in a murine model for erythropoietic protoporphyria.
    Gooijert KE; Havinga R; Oosterloo-Duinkerken AR; Venekamp-Hoolsema EE; Kuipers F; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G510-6. PubMed ID: 17600043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model.
    Abitbol M; Puy H; Sabaté JM; Guénet JL; Deybach JC; Montagutelli X
    Physiol Res; 2006; 55 Suppl 2():S93-101. PubMed ID: 17298226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
    Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of mRNA levels of delta-aminolevulinic acid synthase, ferrochelatase and heme oxygenase-1 in griseofulvin induced protoporphyria mice.
    Inafuku K; Takamiyagi A; Oshiro M; Kinjo T; Nakashima Y; Nonaka S
    J Dermatol Sci; 1999 Apr; 19(3):189-98. PubMed ID: 10215191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport.
    Beukeveld GJ; In 't Veld G; Havinga R; Groen AK; Wolthers BG; Kuipers F
    J Hepatol; 1996 Mar; 24(3):343-52. PubMed ID: 8778203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria.
    Singla A; Moons DS; Snider NT; Wagenmaker ER; Jayasundera VB; Omary MB
    Hepatology; 2012 Jul; 56(1):322-31. PubMed ID: 22334478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.
    Tutois S; Montagutelli X; Da Silva V; Jouault H; Rouyer-Fessard P; Leroy-Viard K; Guénet JL; Nordmann Y; Beuzard Y; Deybach JC
    J Clin Invest; 1991 Nov; 88(5):1730-6. PubMed ID: 1939658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
    J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
    Imoto S; Tanizawa Y; Sato Y; Kaku K; Oka Y
    Br J Haematol; 1996 Jul; 94(1):191-7. PubMed ID: 8757534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy.
    Pawliuk R; Bachelot T; Wise RJ; Mathews-Roth MM; Leboulch P
    Nat Med; 1999 Jul; 5(7):768-73. PubMed ID: 10395321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
    Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
    Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.
    Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
    Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
    Berenson MM; Welch V; Garcia-Marin JJ
    J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.